TrialThe New England journal of medicine2017
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
Richard M Stone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,273 papers cite itlatest 60 shown
this paperpooled ittrialcites it